Slides – Conceptual overview of Manulife's adoption of IFRS 17 and IFRS 9
A conceptual overview of Manulife's adoption of IFRS 17 and IFRS 9
Note: The application of IFRS 17 and IFRS 9 involves significant changes compared with IFRS 4. This presentation intends to provide a simplified education of the key changes and the implications on our financial results, and is not comprehensive or exhaustive
Caution regarding forward-looking statements
From time to time, Manulife makes written and/or oral forward-looking statements, including in this presentation. In addition, our representatives may make forward-looking statements orally to analysts, investors, the media and others. All such statements are made pursuant to the "safe harbour" provisions of Canadian provincial securities laws and the
The forward-looking statements in this presentation include, but are not limited to, statements with respect to the expected improved stability of Manulife's core earnings, net income attributed to shareholders ("net income"), book value and capital (LICAT ratio) under IFRS 17; the impact on net income attributed to shareholders resulting from the application of IFRS 9 hedge accounting; and the stability of expected credit losses in most market conditions; and also relate to, among other things, our objectives, goals, strategies, intentions, plans, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "suspect", "outlook", "expect", "intend", "estimate", "anticipate", "believe", "plan", "forecast", "objective", "seek", "aim", "continue", "goal", "restore", "embark" and "endeavour" (or the negative thereof) and words and expressions of similar import, and include statements concerning possible or assumed future results. Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements and they should not be interpreted as confirming market or analysts' expectations in any way.
Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions (including but not limited to the performance, volatility and correlation of equity markets, interest rates, credit and swap spreads, currency rates, investment losses and defaults, market liquidity and creditworthiness of guarantors, reinsurers and counterparties); the ongoing prevalence of COVID-19, including any variants, as well as actions that have been, or may be taken by governmental authorities in response to COVID-19, including the impact of any variants; changes in laws and regulations; changes in accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements applicable in any of the territories in which we operate; our ability to execute strategic plans and changes to strategic plans; downgrades in our financial strength or credit ratings; our ability to maintain our reputation; impairments of goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting policies, actuarial methods and embedded value methods; our ability to implement effective hedging strategies and unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated liabilities; level of competition and consolidation; our ability to market and distribute products through current and future distribution
channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses; the realization of losses arising from the sale of investments classified as available-for-sale; our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations; the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in models used; political, legal, operational and other risks associated with our non-North American operations; acquisitions or divestitures, and our ability to complete transactions; environmental concerns; our ability to protect our intellectual property and exposure to claims of infringement; and our inability to withdraw cash from subsidiaries.
Additional information about material risk factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Management's Discussion and Analysis in our most recent interim report under "Risk Management and Risk Factors Update" and "Critical Actuarial and Accounting Policies", under "Risk Management and Risk Factors" and "Critical Actuarial and Accounting Policies", in the Management's Discussion and Analysis in our most recent annual report and, in the "Risk Management" note to the consolidated financial statements in our most recent annual and interim reports and elsewhere in our filings with Canadian and
2
IFRS 17/9 do not impact the fundamental economics of our
business, and are expected to improve the stability of earnings,
book value and capital
- IFRS 17/9do not impact the fundamental economics of our business. They impact where, when and how specific items are recognized on the financial statements
- The adoption of IFRS 17/9 isexpected to improve the stability of Manulife's core earnings1, net income, book value and capital (LICAT ratio)
-
- New business gains are capitalized in theContractual Service Margin (CSM)2 and will emerge into earnings over the life of the insurance contract
- Fixed income asset reinvestment activities will be recognized into earnings over the life of the asset
- Changes in retuassumptions for ALDA & public equities are no longer recognized immediately in net income at the time of change, going forward they will flow through core earnings over time
- Manulife elected the Fair Value through Other Comprehensive Income (FVOCI) accounting choice; as a result, much of the interest rate impacts are recorded in Other Comprehensive Income (OCI)
- New drivers of earnings (DOE) analysis is an important tool to understand financial results and replaces the Source of Earnings
- Core earningsmetric continues under IFRS 17 and reflects underlying business performance and earnings generation capacity
- The CSM, including the movement analysis, is a key component of assessing the value of our insurance businesses and our new business generation capacity
3 |
Note: See "Caution regarding forward-looking statements" above. 1 Core earnings is a non-GAAP financial measure. 2 Contractual Service Margin (CSM) represents the unearned profits for a group of insurance contracts. The CSM is a liability which offsets |
new business profits at issue and amortizes into core earnings as insurance services are provided. |
Fair value through OCI choice arising from interest rates
reduces variability in net income
An illustration of hedge accounting impact with fair value through OCI1
- Core earnings and net income attributed to shareholders reflect thebook yield of assets and liabilities, which is aligned with thelong-termnature of our insurance business
- The impact of interest rate movements on our fixed income (FI) assets and liabilities is initially recorded directly on the balance sheet, mostly in OCI, and then reflected in core earnings and net income over time
- Manulife uses derivatives for economic hedging purposes. The mark-to-market on the derivatives is recorded outside of core
earnings, in net income (see slide 8 for more detail). Manulife
applies IFRS 9 hedge accounting to align the presentation of interest rate impacts for fixed income assets, liabilities and derivatives
- However, the application of hedge accounting could result in some noise in net income. We expect thisnoise to decrease over time as we continue to enhance our hedge accounting programs
Without |
Application of |
Hedge Accounting |
Hedge Accounting2 |
Impact of interest rate
movements on
derivatives in net income
Impact of interest rate |
A portion of the |
movements on liability in |
liability impact |
OCI |
goes to net income |
Impact of interest rate movements on FI assets in OCI
With
Hedge Accounting
Impact of interest rate
movements on
derivatives in net income
A portion is transferred to
net income to offset impact on derivatives
The residual portion
remains in OCI
Impact of interest rate movements on FI assets in OCI
4
Legend |
|
1 The size of the boxes in the illustration above are not to scale and do not represent the magnitude |
Net income impact |
of impacts. 2 Hedge accounting ineffectiveness remains in net income. |
OCI impact
IFRS 17 is expected to improve the medium-term stability of core
earnings, net income, book value and capital (LICAT ratio)
IFRS 41
Current period net income
New business gains
Insurance experience gains (losses)
Investing activities
Change in insurance assumptions
Change in retuassumptions - ALDA & public equities
Interest rate impacts
Expected credit losses (ECL)
Other market impacts:
- ALDA and public equities
- Realized gains (losses) on FVOCI fixed income assets
- Hedge ineffectiveness
Impact on stability2: |
|||
Core earnings |
Net income |
Book value LICAT ratio |
|
≈ |
|||
/ |
/ |
/ |
≈ |
≈ ≈
≈
≈
/ |
/ |
≈ |
≈ |
≈ |
/ |
/ |
/ |
Legend |
Improved |
Decreased |
≈Similar |
IFRS 17
Recognition
Recognized in CSM and capital initially and amortized into core earnings over contract life
Variance in claims (current period) recognized in core earnings and variance in reserves (future impact) recognized in CSM 10
Recognized in net income and capital over life of asset
Recognized in CSM and capital and amortized into core earnings over contract life, or immediately into net income if no CSM3
No longer recognized immediately in net income and capital at the time of change, flows through core earnings over time
Elected fair value through OCI, therefore most of the impact is recorded in OCI and CSM.4 Capital sensitivity is expected to reduce
Recognized in core earnings and offset in OCI for most of our FVOCI assets, reflecting change in macro economic environment 11
Overall variability from quarter to quarter is expected to be similar in magnitude as under IFRS 4
Note: See "Caution regarding forward-looking statements" above. 1 This is a simplified view of key components. 2 The impact on stability is directional and there may be variation in the actual results. 3 Change in economic assumptions will be reported through OCI |
||
5 |
or CSM, depending on the type of contracts. For contracts where the change is recorded in CSM, if there is no CSM, it will be recognized immediately into net income. 4 |
For some products the impact will flow through the CSM and into earnings if there is no CSM. |
Attachments
Disclaimer
Slides – 2022 comparative results under IFRS 17 and IFRS 9
C$ unless otherwise stated – Form 6-K
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News